"What do I do now?"
If you or someone you love has just been diagnosed with lung cancer, that's one of the first questions you will ask. It's important to get on the right track right away — seeing the right team, having the right tests, and getting the right treatment, right from the start.
Find the RIGHT TRACK for you
The Right Track is your roadmap to achieve the best possible outcomes in your lung cancer treatment and care. The right team means consulting with specialists who diagnose and treat a high volume of patients with lung cancer. The right test is comprehensive biomarker testing. With the results of these tests, your doctor can determine the right treatment plan for you.
The Right Team
It is best to consult with specialists who diagnose and treat a high volume of patients with lung cancer. You can find these specialists at National Cancer Institute (NCI)-designated and high-volume cancer centers. Seeking a second opinion at any point is also highly recommended to ensure optimal care for lung cancer.
The Right Tests
Every case of lung cancer is different. The right tests can help speed you to a specific diagnosis and a more accurate treatment approach. It is important to have biomarker testing (eg, genomic tests) of your cancer and all other appropriate tests as early as possible to help determine your best treatment options.
The Right Treatment
With the right team and right tests, you have what you need to find the best treatment for your specific diagnosis and access the highest quality of care. Discuss your treatment goals with your healthcare team, and know all of your options at every stage of your disease. Depending on your diagnosis, a clinical trial may be the best option.
The Right Path Forward
The LUNGevity Patient Gateways are a central hub of up-to-date information for your specific type of lung cancer. They share tailored resources, tools to find specialists and learn about clinical trials, and timely research updates so you have all the information to live well with your type of lung cancer.